for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Kissei Pharmaceutical Co Ltd

4547.T

Latest Trade

2,858.00JPY

Change

-1.00(-0.03%)

Volume

43,500

Today's Range

2,851.00

 - 

2,880.00

52 Week Range

2,309.00

 - 

3,210.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
2,859.00
Open
2,851.00
Volume
43,500
3M AVG Volume
1.16
Today's High
2,880.00
Today's Low
2,851.00
52 Week High
3,210.00
52 Week Low
2,309.00
Shares Out (MIL)
46.72
Market Cap (MIL)
148,128.20
Forward P/E
--
Dividend (Yield %)
1.78

Next Event

Dividend For 4547.T - 26.0000 JPY

Latest Developments

More

Kissei Pharmaceutical says marketing approval for "Beova® Tablets 50mg" for treatment of overactive bladder

Kissei Pharmaceutical says change of president

Kissei Pharmaceutical says rating withdrawal by R&I

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Kissei Pharmaceutical Co Ltd

KISSEI PHARMACEUTICAL CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. It is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.

Contact Info

19-48, Yoshino

+81.263.259081

http://www.kissei.co.jp

Executive Leadership

Mutsuo Kanzawa

Chairman of the Board, Chief Executive Officer, Representative Director

Yoshio Furihata

President, Chief Operating Officer, Representative Director

Hiroe Sato

Vice President, Director

Keiji Fukushima

Managing Director, Chief Director of Pharmaceutical Sales

Yasuo Takehana

Managing Director, Director of Business Planning

Key Stats

3.00 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2017

0.1K

2018

0.1K

2019

0.1K

2020(E)

0.1K
EPS (JPY)

2017

158.740

2018

188.260

2019

117.330

2020(E)

82.434
Price To Earnings (TTM)
28.10
Price To Sales (TTM)
2.26
Price To Book (MRQ)
0.69
Price To Cash Flow (TTM)
20.01
Total Debt To Equity (MRQ)
1.89
LT Debt To Equity (MRQ)
0.99
Return on Investment (TTM)
2.40
Return on Equity (TTM)
2.24

Latest News

Latest News

BRIEF-Kissei Pharmaceutical says change of president

* Says it appoints Yoshio Furihata as president, to succeed Masaki Morozumi, effective June 27

BRIEF-Kissei Pharmaceutical completes share repurchase

* Says it completed repurchase of 1.6 million shares of its common stock, for 4.46 billion yen in total, through ToSTNeT-3, on Feb. 13

BRIEF-Kissei Pharmaceutical to repurchase up to 3.7 pct shares and retire treasury shares

* Says it will repurchase up to 1.8 million shares, representing 3.7 percent of outstanding, for up to 5.02 billion yen, through ToSTNeT-3, on Feb. 13

BRIEF-R&I affirms Kissei Pharmaceutical's rating at "A-" and says stable outlook - R&I

* Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A-" - R&I

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up